July 30, 2021 at 10:46PM CMC and GMP Guidances

This page lists CMC and GMP Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2pNxND1

July 30, 2021 at 06:28PM Exceptions and Alternative Procedures Approved Under 21 CFR 640.120

Title 21 Code of Federal Regulations 640.120(a) - The Director, Center for Biologics Evaluation and Research, may approve an exception or alternative procedures to any requirement in subchapter F (Biologics) of Chapter I (Parts 600 - 680) of title 21 of the Code of Federal Regulations regarding bloo

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ZCEYhG

July 29, 2021 at 07:05PM FDA 101: Product Recalls

Here's a breakdown of FDA's role in product recalls, from the moment the agency is notified to successful completion of the recall.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Su3EFo

July 29, 2021 at 06:02PM Identifying Recalled Products

Think you may have a recalled product? Watch this video to learn who to contact and how to identify a recalled product by the numbers and dates on the packaging.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3hdFRSQ

July 29, 2021 at 04:08PM Roster of the Cellular, Tissue and Gene Therapies Advisory Committee

This is the Roster of the Cellular, Tissue and Gene Therapies Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2O2NW3e

July 28, 2021 at 02:59PM Biosimilar and Interchangeable Biologics: More Treatment Choices

The FDA has approved biosimilar medications to treat conditions such as cancer, diabetes, Crohn’s disease, colitis, rheumatoid arthritis, psoriasis, and more.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2QFSPOz

Tuesday, July 27, 2021

July 26, 2021 at 03:09PM Seraclone Blood Grouping Reagent Anti-Fya(Monoclonal)

Product approval information is indicated for the determination of the blood group antigens on red blood cells using the tube test.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3BXz7UP

July 26, 2021 at 05:12PM Seraclone Blood Grouping Reagents and Anti-Human Globulin Reagents (STN# 125213, 125215, 125217, 125219 - 125233, 125242)

Product approval information is indicated for the determination of the blood group antigens on red blood cells and detecting in vivo and /or in vitro coating of red blood cells using the tube test.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3f0hg5K

July 26, 2021 at 03:43PM Biotestcell and Erytypecell

Product approval information is indicated for use in manual tube testing and Reagent Red Blood Cells For Use in Automated Systems are for use on the TANGO® optimo automated blood grouping and antibody test system.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3zGEDsL

July 27, 2021 at 09:40PM Vaccines Research

List of Vaccines Research.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2VeqHUs

July 27, 2021 at 09:35PM Evaluation of the Quality of Viral Vaccines Based on Molecular Consistency

A description of Konstantin Chumakov's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2UMsMuD

July 27, 2021 at 08:47PM 2021 Meeting Materials, Cellular, Tissue and Gene Therapies Advisory Committee

This is the main page for the CBER 2021 Meeting Materials, Cellular, Tissue and Gene Therapies Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ZmaIGl

July 27, 2021 at 08:46PM Cellular, Tissue, and Gene Therapies Advisory Committee September 2-3, 2021 Meeting Announcement - 09/02/2021 - 09/03/2021

This is the CBER Cellular, Tissue, and Gene Therapies Advisory Committee September 2-3, 2021 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Vhxi3P

July 27, 2021 at 07:09PM Development of Quantitative Assays to Evaluate the Safety of Cell Substrates and Vaccines

A description of Keith Peden's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2PMmAMJ

July 26, 2021 at 08:41PM IDELVION

Product approval information is indicated for children and adults with hemophilia B (congenital Factor IX deficiency) for 1) On-demand control and prevention of bleeding episodes; 2) Perioperative management of bleeding; 3) Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2oyFIU5

July 27, 2021 at 04:52PM Influenza neuraminidase antigenicity and efficacy in vaccines

Robert Daniels' research project "Influenza neuraminidase antigenicity and efficacy in vaccines".

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/30Uymdk

July 26, 2021 at 10:51PM Development of New Immunological Assays and Animal Models to Evaluate Vaccine Safety and Efficacy Against Emerging Diseases

A description of H. Golding's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2UUyVER

July 26, 2021 at 09:23PM Emergency Use Authorization for Vaccines to Prevent COVID-19

This is the Guidance for Industry for the Emergency Use Authorization for Vaccines to Prevent COVID-19. , COVID-19, Coronavirus Disease 2019, Vaccines , CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3iF3PqC

July 26, 2021 at 04:14PM SHINGRIX

This is the main page for the CBER SHINGRIX.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3rdNC00

July 21, 2021 at 04:50PM FluMist Quadrivalent

For active immunization of individuals 2 through 49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2k4W45k

July 23, 2021 at 01:54AM 2021_07 Test Article EDITED FT 01

2021_07 Test Article some long description some long description.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3eLLtFu

July 22, 2021 at 11:17PM Janssen COVID-19 Vaccine Frequently Asked Questions

Answers to frequently asked questions about FDA's Emergency Use Authorization of the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3uz7cH3

July 22, 2021 at 03:48PM FDA Seeks Patient Insight: Call for Applications for the Patient Engagement Collaborative

The FDA is announcing the call for applications for the next cohort of the Patient Engagement Collaborative.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3iyxDYc

July 22, 2021 at 03:28PM Field Alert Report Submission: Questions and Answers Guidance for Industry

Pharmaceutical Quality/Manufacturing Standards (CGMP).
and Pharmaceutical Quality/CMC.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3frF5kL

July 20, 2021 at 08:53PM FDA Patient Engagement Opportunities

A description of some of the opportunities for patients, caregivers and advocates to engage with the FDA.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32lI6PF

July 20, 2021 at 08:35PM Patient Engagement Collaborative

The Patient Engagement Collaborative (PEC) is an advancement in the FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Office of Patient Affairs in the Office of Clinical Policy and Programs (OCPP).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2P5qy5N

Wednesday, July 21, 2021

July 21, 2021 at 04:04PM Human Gene Therapy for Neurodegenerative Diseases

This is the draft guidance for industry, Human Gene Therapy for Neurodegenerative Diseases.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3okVHiW

Monday, July 19, 2021

July 19, 2021 at 11:16PM Remarks by Dr. Woodcock to the Regulatory Education for Industry Conference - 07/19/2021

Remarks by Janet Woodcock, MD
Acting Commissioner of Food and Drugs
2021 FDA Regulatory Education for Industry Conference
July 19, 2021
White Oak, MD

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3wPT0t8

July 19, 2021 at 03:36PM Global Regulators Envision Paradigm Shift Toward Inclusion of Pregnant and Breastfeeding Women in Clinical Research for Medicines and Vaccines

A major paradigm shift is necessary from the systemic exclusion to the inclusion of pregnant and breastfeeding women in clinical studies.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3ipjUTj

July 16, 2021 at 01:15PM Real-World Evidence

Real-world data (RWD) and real-world evidence (RWE) played an increasing role in health care decisions. The 21st Century Cures Act, passed in 2016, placed additional focus on the use of these types of data to support regulatory decision making.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2QHG6v0

July 15, 2021 at 06:30PM Global Unique Device Identification Database (GUDID): Data Submission Compliance Date of September 24, 2015

Global Unique Device Identification Database (GUDID): Data Submission Compliance Date of September 24, 2015 - Guidance for Industry and FDA Staff

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2J9D4LB

July 14, 2021 at 07:03PM Improving Safety and Potency Testing of Allergen Extracts

A description of Jay Slater's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ZNvArc

July 14, 2021 at 04:47PM PREA Non-Compliance Letters

PREA Non-Compliance Letters

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3iaguUn

Tuesday, July 13, 2021

July 13, 2021 at 10:51PM Coronavirus (COVID-19) Update: July 13, 2021

Coronavirus (COVID-19) Update: July 13, 2021

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3i880wR

July 13, 2021 at 10:26PM Fast Track Designation Request Performance

The Food and Drug Administration Modernization Act of 1997 (FDAMA) includes Section 112, "Expediting study and approval of fast track drugs." This section mandates the Agency to facilitate the development and expedite review of drugs and biologics intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Fast track adds to existing programs, such as accelerated approval, the possibility of a "rolling submission" for a marketing application. An important feature of fast track is that it emphasizes the critical nature of close early communication between the FDA and sponsor to improve the efficiency of product development.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2N7vN39

Monday, July 12, 2021

July 13, 2021 at 03:44AM 2021_07 Test Article FT 01

2021_07 Test Article some long description some long description.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3i1uaRp

July 12, 2021 at 10:43PM COVID-19 Vaccine Safety Surveillance

This page describes the monitoring the safety of authorized COVID-19 vaccines through both passive and active safety surveillance systems.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3jwsGPE

July 12, 2021 at 10:43PM Initial Results of Near Real-Time Safety Monitoring of COVID-19 Vaccines in Persons Aged 65 Years and Older

This page describes the Initial Results of Near Real-Time Safety Monitoring of COVID-19 Vaccines in Persons Aged 65 Years and Older

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3e7av1m

July 12, 2021 at 05:07PM FDA to Discuss COVID-19’s Impact on Medical Product Operations at SBIA REdI Annual Conference

FDA will co-host the Small Business Industry and Assistance (SBIA) Regulatory Education for Industry (REdI) Annual Conference, which will provide an overview of our regulatory operations during COVID-19.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3ATDH5E

July 12, 2021 at 02:10PM Blood & Blood Products

CBER regulates the collection of blood and blood components used for transfusion or for the manufacture of pharmaceuticals derived from blood and blood components. FDA has strengthened the safeguards that protect patients from unsuitable blood and blood products and has increased its oversight of the blood industry.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/30NFqIi

July 12, 2021 at 02:08PM Regulation of the Blood Supply

Regulation of the Blood Supply

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2MMuis2

July 09, 2021 at 10:41PM FDA Patient Listening Sessions

Patient Listening Sessions led by FDA’s Office of Patient Affairs provide an opportunity for medical product Centers to engage with patients, caregivers, and advocates about their experiences and perspectives.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3b0WJM9

July 09, 2021 at 10:10PM Coronavirus (COVID-19) Update: July 9, 2021

Coronavirus (COVID-19) Update: July 9, 2021

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3yLY6bd

July 09, 2021 at 09:18PM Joint CDC and FDA Statement on Vaccine Boosters

Joint CDC and FDA Statement on Vaccine Boosters

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3jYS5ni

July 09, 2021 at 08:21PM Questions and Answers Regarding the End of the Compliance and Enforcement Policy for Certain Human Cells, Tissues, or Cellular or Tissue-based Products (HCT/Ps)

This is the CBER HCT/Ps Q&As- End of Compliance and Enforcement Policy main page with information for health care providers, clinics and regulated industry need to know about the end of FDA's compliance and enforcement policy, which ended on May 31, 2021 if they offer certain HCT/Ps.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2TY4eOy

July 09, 2021 at 06:16PM Cellular & Gene Therapy Products

CBER provides oversight of clinical studies, proactive scientific and regulatory advice to medical researchers and manufacturers of cellular therapy products, human gene therapy products, and certain devices related to cell and gene therapy.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Ap1HU3

July 09, 2021 at 06:28PM Biosimilars Guidances

This page lists Biosimilars Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3e1ZPkN

July 09, 2021 at 03:52PM Influenza Virus Vaccine Composition and Lot Release

Influenza Virus Vaccine Composition and Lot Release

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/38nJP8H

July 07, 2021 at 10:42PM OCTAGAM

Product approval information is indicated for the treatment of chronicimmune purpura (ITP) in adults

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3qULyvl